Document is current
Any future updates will be listed below
-
Authors
Xie, Huangfan
Li, Guangya
Fu, Yunxi
Jiang, Nan
Yi, Simeng
Kong, Xi
Shi, Jihang
Yin, Shigang
Peng, Jianhua
Jiang, Yong
Lu, Shichun
Deng, Hongkui
Xie, Bingqing https://orcid.org/0000-0001-9433-1641
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (32300675, 32288102)
Sichuan Science and Technology Program (2022YFS0615)
Luzhou Science and Technology Bureau (2023SYF136)
Luzhou Science and Technology Program of China (2023JYJ019)
Doctoral Research Initiation Fund of Affiliated Hospital of Southwest Medical University (22069, 22070)
- License Information
-
More Information
Article History
Received: 6 May 2024
Accepted: 29 August 2024
First Online: 4 September 2024
Declarations
:
: All research using Tet-uPA/Rag2–/–/γc–/– (URG) mice was approved by IACUC Committee of Beijing Vitalstar Biotechnology Co., Ltd, titled “Planning research and experimental procedures on animals” (Ethical approval No.: VST-SY-2023101501, approval date: 28 Oct 2023). All research using primary human hepatocytes was approved by the Research Ethics Committee of Chinese PLA General Hospital (Ethical approval No.: S2020-137-01, renewed on 30 April 2020) with informed written consent, titled “Research on obtaining primary human hepatocytes from discarded human liver tissue after surgical resection”.
: Not applicable.
: The authors declare that there are no competing interests.
